Skip to main content

iwCLL 2025 Main banner

iwCLL X / Twitter

116 Views

Poster

1704 - Feasibility of an individualized physical activity Intervention in CLL patients receiving ibrutinib +/-venetoclax: preliminary results from the QOLIBRI Study

Primary Author / Presenter(s)

Loic Ysebaert, MD, PhD

Professor of Hematology
IUCT Oncopole
Toulouse, Midi-Pyrenees, France

Co-Author(s)

ET

Emmanuelle Tchernonog, MD

CHU Montpellier
Montpellier, France
CB

Come Bommier, MD

Hopital Saint-Louis (APHP), Paris
Paris, Ile-de-France, France
NT

Nathalie Texier, PharmD

Kappa Santé
PARIS, Ile-de-France, France
MC

Mathilde Coint-Bavarot, PharmD

Kappa Santé
Paris, Ile-de-France, France
AS

Alberto Santagostino, MD

CH de Troyes
Troyes, Champagne-Ardenne, France
OF

Olivier Fitoussi, MD

Polyclinique Bordeaux Nord Aquitaine
Bordeaux, Aquitaine, France
NS

Nathalie Saint Gerard

Janssen-Cilag France
Issy les moulneaux, Ile-de-France, France
SD

Sandrine Dupuis, MD

Janssen-cilag France
Issy-les-Moulineaux, France
TK

Thilina Kariyawasam

Janssen-Cilag France
issy les moulineaux, Ile-de-France, France
GO

Gaelle Olivier, MD

Ch Niort
Niort, Limousin, France
NA

Nicolas Albin, MD

GH Mutualiste de Grenoble
Grenoble, Rhone-Alpes, France
LD

Lidia Delrieu, PhD

Institut national du sport, de l'expertise et de la performance
Paris, Ile-de-France, France